SIMONATO, Michele
 Distribuzione geografica
Continente #
NA - Nord America 11.379
EU - Europa 4.967
AS - Asia 2.754
SA - Sud America 298
AF - Africa 24
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 19.427
Nazione #
US - Stati Uniti d'America 11.351
PL - Polonia 1.893
CN - Cina 1.091
SG - Singapore 1.086
IT - Italia 661
UA - Ucraina 623
DE - Germania 486
TR - Turchia 363
RU - Federazione Russa 350
GB - Regno Unito 315
BR - Brasile 265
FI - Finlandia 229
SE - Svezia 125
FR - Francia 93
ID - Indonesia 68
CZ - Repubblica Ceca 52
AT - Austria 43
HK - Hong Kong 39
VN - Vietnam 31
BE - Belgio 25
NL - Olanda 25
CA - Canada 17
IN - India 14
LT - Lituania 14
CO - Colombia 13
IR - Iran 13
ZA - Sudafrica 11
PK - Pakistan 7
AR - Argentina 6
ES - Italia 6
IE - Irlanda 6
KR - Corea 6
IQ - Iraq 5
KE - Kenya 5
PT - Portogallo 5
CH - Svizzera 4
EC - Ecuador 4
MA - Marocco 4
MX - Messico 4
AU - Australia 3
BD - Bangladesh 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
JO - Giordania 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
UZ - Uzbekistan 2
BG - Bulgaria 1
CR - Costa Rica 1
DZ - Algeria 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 19.427
Città #
Warsaw 1.892
Fairfield 1.546
Woodbridge 1.533
Houston 856
Ashburn 824
Jacksonville 719
Chandler 675
Ann Arbor 607
Seattle 603
Santa Clara 569
Singapore 547
Wilmington 539
Cambridge 502
Beijing 254
Nanjing 231
Izmir 229
Ferrara 210
Princeton 169
San Diego 147
Shanghai 95
Milan 93
New York 92
Helsinki 91
Boardman 88
Los Angeles 73
Jakarta 65
Nanchang 64
Shenyang 56
Jiaxing 49
Washington 49
Dearborn 42
Brno 41
Hong Kong 39
Changsha 35
Vienna 34
Bremen 33
Hebei 33
Munich 32
London 31
Norwalk 31
Dong Ket 30
Tianjin 30
Kunming 29
Falkenstein 26
Redwood City 26
Brussels 24
Mountain View 24
Bologna 23
Jinan 23
San Mateo 23
The Dalles 23
Auburn Hills 22
Ningbo 22
Rome 20
Falls Church 18
Zhengzhou 18
Des Moines 16
São Paulo 16
Verona 16
Bogotá 12
Nuremberg 12
Toronto 12
Council Bluffs 11
Frankfurt am Main 11
Philadelphia 11
Augusta 10
Guangzhou 10
Rio de Janeiro 10
Tappahannock 10
Düsseldorf 9
Hangzhou 9
Orange 9
Phoenix 9
Kilburn 8
Lappeenranta 8
Olomouc 8
Redmond 8
Taizhou 8
Changchun 7
Lanzhou 7
Leawood 7
Addison 6
Ardabil 6
Dublin 6
Modena 6
Haikou 5
Monmouth Junction 5
Nairobi 5
Nova Friburgo 5
Parma 5
Pisa 5
San Giovanni in Persiceto 5
Amsterdam 4
Arezzo 4
Brasília 4
Chicago 4
Contagem 4
Fortaleza 4
Goiânia 4
Hefei 4
Totale 14.544
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 461
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 331
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 301
Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus 299
WONOEP appraisal: New genetic approaches to study epilepsy 288
Meta-analysis of microRNAs dysregulated in the hippocampal dentate gyrus of animal models of epilepsy 287
Standardization procedure for plasma biomarker analysis in rat models of epileptogenesis: Focus on circulating microRNAs 286
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 285
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 280
Harmonization in preclinical epilepsy research: A joint AES/ILAE translational initiative 278
Progress in gene therapy for neurological disorders 277
The challenge and promise of anti-epileptic therapy development in animal models 277
Identification and characterization of outcome measures reported in animal models of epilepsy: Protocol for a systematic review of the literature-€“A TASK2 report of the AES/ILAE Translational Task Force of the ILAE 256
Fisiologia e fisiopatologia di BDNF: verso lo sviluppo di nuove strategie terapeutiche per alcune delle principali malattie neuro-psichiatriche 186
Engineered HSV vector achieves safe long-term transgene expression in the central nervous system 161
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 158
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 153
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 153
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 153
A pathogenetic hypothesis of temporal lobe epilepsy 148
Kainate seizures increase nociceptin/orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study 148
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 148
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 144
Personalized needles for microinjections in the rodent brain 142
5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices. 142
Advances in the development of biomarkers for epilepsy 141
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 140
Angels and demons: neurotrophic factors and epilepsy 139
Loss of cortical GABA terminals in Unverricht–Lundborg disease 139
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors 137
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 136
Characterization of K+-evoked [3H]d-aspartate outflow in the rat hippocampus in vitro 135
Silencing status epilepticus-induced BDNF expression with herpes simplex virus type-1 based amplicon vectors 134
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 133
Characterization of glutamate and [3H]D-aspartate outflow from various in vitro preparations of the rat hippocampus. 133
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 133
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 132
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 132
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 132
GABAA-Current Run-down of Temporal Lobe Epilepsy is Associated with Repetitive Activation of GABAA "Phasic" Receptors 129
eIF4B phosphorylation at Ser504 links synaptic activity with protein translation in physiology and pathology 129
Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives 128
The neurochemistry of morphine addiction in the neocortex. 128
Antinociceptive activity of the N-Methyl-D- Aspartate Receptor Antagonist N-(2-indanyl)-glycinamide hydrochloride CHF3381 in Experimental Models of Inflammatory and Neuropathic Pain 127
Effect of arachidonic acid on [3H]d-aspartate outflow in the rat hippocampus 126
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 126
Induction of B-1 bradykinin receptors in the kindled hippocampus increases extracellular glutamate levels: A microdialysis study 126
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 124
Changes in NPY-mediated modulation of hippocampal [H-3]D-aspartate outflow in the kindling model of epilepsy 123
null 123
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 123
Fibroblast Growth Factor-2 (FGF-2). 122
Dose- and time-dependent hippocampal cholinergic lesions induced by ethylcholine mustard aziridinium ion: effects of nerve growth factor, GM1 ganglioside and vitamin E 121
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 121
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 121
Involvement of the neuropeptide Orphanin FQ/Nociceptin in kainate and kindling seizures and epileptogenesis. 120
Common data elements and data management: Remedy to cure underpowered preclinical studies 120
Induction of B1 bradykinin receptors in the kindled brain. 119
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 119
Biotin-deficiency facilitates kindling hyperexcitability in rats. 119
Early changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures in the rat. 119
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 119
Differential expression of immediate early genes in the hippocampus in the kindling model of epilepsy 118
Gene Therapy Tools for Brain Diseases 117
Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine 116
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 116
Mechanisms of action of CHF3381 in the forebrain 115
WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients? 114
Strafatti - Nient'altro che fatti sulle droghe più usate e abusate - dall'alcol all'ecstasy 113
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 113
Evaluation of cell damage in organotypic hippocampal slice culture from adult mouse: a potential model system to study neuroprotection 112
Opportunities for improving animal welfare in rodent models of epilepsy and seizures 112
null 111
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 111
Targeting kinin receptors for the treatment of neurological diseases 110
Cell Therapy for Epilepsy 109
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 109
Identification of new epilepsy treatments for: issues in preclinical methodology 108
Finding a better drug for epilepsy: Preclinical screening strategies and experimental trial design 108
BODIPY (R)-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes 108
Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy 107
Differences in the anatomic distribution of immediate-early gene expression in amygdala and angular bundle kindling development 105
Long-term, targeted delivery of GDNF from encapsulated cells is neuroprotective and reduces seizures in the pilocarpine model of epilepsy 105
Alpha-2 adrenoceptors on cortical gaba terminals shift to a high affinity state in morphine-dependent guinea-pigs 105
Opioid peptides and seizures. 104
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance. 104
Kindled seizure-induced c-fos and prodynorphin mRNA expressions are unrelated in the rat brain. 103
Finding a better drug for epilepsy: Antiepileptogenesis targets 103
What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development. 103
On the role of somatostatin in seizure control: Clues from the hippocampus 103
Circadian differences in the individual sensitivity to opiate overdose 102
Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus. 101
Time- and region-specific variations in somatostatin release following amygdala kindling in the rat 101
Unverricht-Lundborg disease 100
Preclinical evaluation of CHF3381 as a novel antiepileptic agent. 100
Binding to adenosine receptors in rat brain in the kindling model of epilepsy 99
Temporal lobe epilepsy model, neural stem cells and gene therapy 99
New tools for epilepsy therapy 99
BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae 98
Region-specific changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures. 98
Totale 14.529
Categoria #
all - tutte 92.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.295
Totale 95.525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020340 0 0 0 0 0 0 0 0 0 0 218 122
2020/20212.528 203 254 132 247 140 242 138 283 111 353 281 144
2021/20221.730 58 233 132 51 37 57 99 114 74 116 185 574
2022/20231.607 192 68 104 160 247 221 66 180 205 12 99 53
2023/20241.348 96 109 63 24 94 278 111 142 77 81 64 209
2024/20253.013 133 115 337 174 450 439 84 188 650 397 46 0
Totale 19.712